Consider a case where a patient has a disease with high mortality and no effective treatment available. A new experimental drug is now being tested in a clinical trial. However, this is a randomized clinical trial, which means that it will have a treatment group and a placebo group (that does not get the actual drug).
Uncategorized
BIO 2014: Antisense and Disruptive Technologies for Drug Discovery | Xconomy
BIO 2014: Antisense and Disruptive Technologies for Drug Discovery | Xconomy.
Featured
Promoting Innovation While Ensuring Safety of Biosimilars: Two Perspectives at #BIO2014
The second day of BIO 2014 International Convention, Tuesday June 24th, presented at least two opportunities to learn about biosimilars, which haven?t only been gaining momentum from research and development over the last several years, […]
Featured
SDBN’s #BIO2014 Snapshot 5/16/2014
Here is our latest summary of news and events about the upcoming Biotechnology Industry Organization 2014 convention happening in San Diego June 23-26: Hillary Rodham Clinton Keynote. Former Secretary of State Hillary Rodham Clinton will […]
